Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch...
System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(2)
•••
MustangSalley
X
View Profile
View Bullboard History
Comment by
MustangSalley
on Sep 08, 2022 12:34pm
RE:ViaCyte
Viacyte has another device with stem cells using Crispers technology that makes the cells avoid the immune system and implanted in a patient ! Philip can't even get 7 th patient .
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 08, 2022 7:30am
New Press Release - Sernova to Present at H.C. Wainwright Annual Global Investment Conference and LifeSci Partners HealthTech Symposium
LONDON, Ontario, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced it will be presenting at the upcoming H.C. Wainwright 24th Annual Global Investment Conference...
read article.
Fintech Select LTD. Publishes Results for Fiscal Year 2023
posted May 01, 2024 9:00am by
Fintech Select Ltd.
-
|
Under the leadership of Fintech Select's management, the Company achieved a significant milestone in revenue generation, reaching $3,822,182 for fiscal year 2023, compared to $2,587,867 in 2022. Management is confident this 47% increase on a year-over-year basis ...read more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on Sep 08, 2022 2:12am
ViaCyte
VileSight still pushing hard. https://twitter.com/ViaCyte/status/1488881033235808262 .
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on Sep 08, 2022 1:49am
Conformal Coating
Since management won't provide any updates, we have to be resourceful. Sorry Spill! There is a link in this article to the full paper for those interested. https://physician-news.umiamihealth.org
...more
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on Sep 07, 2022 11:53am
RE:New director
Bio...better jet he I am sure he will be keeping the lid on the cookie jar.
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on Sep 07, 2022 9:29am
New director
Looks like this guy could make a great replacement to spill as ceo. Hopefully puts that capital market knowledge to use.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 07, 2022 7:30am
New Press Release - Sernova Announces the Appointment of Daniel Mahony, Ph.D. to its Board of Directors
- Successful biopharma entrepreneur with 25 years of experience growing leading healthcare firms - LONDON, Ontario, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today...
read article.
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on Sep 04, 2022 2:56am
RE:RE:RE:RE:RE:Dear Evotec...
quest... I too think k that $1.70 is way below value but when I look at the 3 year chart, I see an unmitigated disaster. I don't usually give much weight to charts and TA on their own but I can
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Sep 04, 2022 2:44am
RE:RE:RE:Imposter
Not at all. It'll be obvious to those who "know" me from here if someone with the same handle starts pumping SVA over there. And to those who don't know me then it's just another
...more
(137)
•••
MoneyMouth
X
View Profile
View Bullboard History
Comment by
MoneyMouth
on Sep 02, 2022 11:51pm
RE:RE:Imposter
Im sure you too would be like wtf if suddenly a bioteck showed up on ceo
(14)
•••
quest13
X
View Profile
View Bullboard History
Comment by
quest13
on Sep 02, 2022 9:49pm
RE:RE:RE:RE:Dear Evotec...
MetalsGuy1, I certainly agree with you that if there is a deal for a buyout accepted by management and major shareholders then I would really like it to be a share deal. Of course I feel that it is
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Sep 02, 2022 6:32pm
RE:Imposter
Lol don't flatter yourself money. We all know the real money mouth is long on sva. Not like you have a following who will be confused by the CEO posts.
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on Sep 02, 2022 5:57pm
RE:RE:RE:Dear Evotec...
quest13 what are you the Forest Gump of investing. While I agree with BioTek in that I would vote yes inan offer 1.70. My preference would be a share deal. Evotec is a management team I could get
...more
(137)
•••
MoneyMouth
X
View Profile
View Bullboard History
Post by
MoneyMouth
on Sep 02, 2022 5:33pm
Imposter
I don't know which one of you retards are trying to be me on ceo.ca but like atleast try to act in character...
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project